Occupational exposure to anticancer drugs — Potential and real hazards
- 1 September 1985
- journal article
- research article
- Published by Elsevier in Mutation Research/Reviews in Genetic Toxicology
- Vol. 154 (2), 135-149
- https://doi.org/10.1016/0165-1110(85)90024-7
Abstract
No abstract availableThis publication has 55 references indexed in Scilit:
- A Study of Occupational Exposure to Antineoplastic Drugs and Fetal Loss in NursesNew England Journal of Medicine, 1985
- CHLORAMBUCIL-INDUCED CHROMOSOME DAMAGE TO HUMAN LYMPHOCYTES IS DOSE-DEPENDENT AND CUMULATIVEThe Lancet, 1984
- Leukemia and Preleukemia after Adjuvant Treatment of Gastrointestinal Cancer with Semustine (Methyl-CCNU)New England Journal of Medicine, 1983
- Acute and long-term cytogenetic effects of treatment in childhood cancer sister-chromatid exchanges and chromosome aberrationsMutation Research, 1982
- LACK OF MUTAGENIC ACTIVITY IN URINE FROM HOSPITAL PHARMACISTS ADMIXING ANTITUMOUR DRUGSThe Lancet, 1981
- Platinum compounds with anti-tumour activityToxicology, 1980
- Cyclophosphamide: Pilot study of genetically active metabolites in the urine of a treated human patient induction of mitotic gene conversions in yeastMutation Research, 1973
- Methylation of nucleic acids and urinary excretion of 14C-labeled 7-methylguanine by rats and man after administration of 4(5)-(3,3-Dimethyl-1-triazeno)-imidazole 5(4)-carboxomideToxicology and Applied Pharmacology, 1971
- Induction of thymic lymphosarcoma and mammary adenocarcinomas in rats by oral administration of the antitumor agent4(5)-(3,3-dimethyl-l-triazeno)imidazole-5(4)-carboxamideCancer, 1970
- Interstrand cross-linking of DNA by difunctional alkylating agentsJournal of Molecular Biology, 1967